Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanreqing Oral Liquid for Moderate to Severe Common Cold (Wind-Heat Invading Lung) – Phase III Double-Blind RCT
CTR20200966Phase 3Active
- Sponsor
- Henan Xinyi Pharmaceutical
- Start
- Jun 2020
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tanreqing in nasopharyngitis (2 arms), sponsored by Henan Xinyi Pharmaceutical. Started Jun 2020; status: active.
02
Drugs
tanreqing
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20200966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200966.